Pilot randomised controlled trial of meropenem versus piperacillin-tazobactam for the definitive treatment of bloodstream infections caused by AmpC beta-lactamase producing Enterobacter spp, ... (2015)
Experts
Dr
Patrick Harris
NHMRC Emerging Leadership Fellow
UQ Centre for Clinical Research
Faculty of Health, Medicine and Behavioural Sciences
Associate Professor, Infectious Diseases
UQ Centre for Clinical Research
Faculty of Health, Medicine and Behavioural Sciences